Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-24 @ 3:44 PM
NCT ID:
NCT00530192
Eligibility Criteria:
Inclusion Criteria:
* Metastatic cancer which has progressed on 2 prior chemotherapeutic, hormonal or biological regimens for advanced disease.
* Be defined as refractory to the last line of therapy
* Have documentation of the best clinical response to the treatment regimen immediately prior to entering this study
Exclusion Criteria:
* Patients with symptomatic CNS metastasis
* Any previous history of another malignancy within 5 years of study entry
* Uncontrolled intercurrent illness
* Known HIV, HBV, HCV infection
* Pregnant or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00530192
Study Brief:
Protocol Section:
NCT00530192